Employees: NN (None)Legal category: 5485Size: PMECreation date: 2015-05-12 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PIRE-CHANCE (35150), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE PIRE : revenue, balance sheet and financial ratios
PHARMACIE DE PIRE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PIRE-CHANCE (35150),
this company of category PME
shows in 2022 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE PIRE (SIREN 811996677)
Indicator
2023
2022
2021
2020
2019
Revenue
N/C
1 180 781 €
N/C
N/C
N/C
Net income
43 947 €
66 960 €
36 273 €
32 670 €
30 575 €
EBITDA
N/C
88 700 €
N/C
N/C
N/C
Net margin
N/C
5.7%
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DE PIRE generates positive net income of 44 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2023: 31 k€ -> 44 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
43 947 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.797%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.851%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Debt ratio
299.416
189.062
125.786
78.518
48.797
Financial autonomy
20.812
28.61
35.668
43.97
54.851
Repayment capacity
None
None
None
2.414
None
Cash flow / Revenue
None%
None%
None%
5.876%
None%
Sector positioning
Debt ratio
48.82023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Good-18 pts over 3 years
In 2023, the debt ratio of PHARMACIE DE PIRE (48.80) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
54.85%2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Good+20 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DE PIRE (54.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
2.41 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE DE PIRE (2.41) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 198.09. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
198.095
Liquidity indicators evolution PHARMACIE DE PIRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
Liquidity ratio
111.713
129.062
142.554
182.396
198.095
Interest coverage
None
None
None
2.283
None
Sector positioning
Liquidity ratio
198.092023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Good+26 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE PIRE (198.09) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.28x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE DE PIRE (2.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE PIRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
15 492 €
0 €
Inventory turnover (days)
0
0
0
11
0
Customer payment term (days)
0
0
0
0
0
Supplier payment term (days)
0
0
0
29
0
Positioning of PHARMACIE DE PIRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE PIRE is estimated at
518 551 €
(range 315 356€ - 728 967€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
315k€518k€728k€
518 551 €Range: 315 356€ - 728 967€
NAF 5 année 2023
Valuation method used
Net Income Multiple
43 947 €
×
11.8x
=518 552 €
Range: 315 356€ - 728 967€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE PIRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE PIRE
What is the revenue of PHARMACIE DE PIRE ?
The revenue of PHARMACIE DE PIRE in 2022 is 1.2 M€.
Is PHARMACIE DE PIRE profitable?
Yes, PHARMACIE DE PIRE generated a net profit of 44 k€ in 2023.
Where is the headquarters of PHARMACIE DE PIRE ?
The headquarters of PHARMACIE DE PIRE is located in PIRE-CHANCE (35150), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE DE PIRE ?
The tax return of PHARMACIE DE PIRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE PIRE operate?
PHARMACIE DE PIRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart